Literature DB >> 19924606

Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients.

A Gul1, M A Rahman, S N Hasnain.   

Abstract

BACKGROUND: Fructose intake has been increased steadily during the past two decades. Fructose, like other reducing sugars can react with proteins, which may account for aging and myocardial infarction. Fructose participates in glycation (fructation) and AGE formation some 10 times faster than glucose. This study aims to determine the fructose concentration and correlate with antioxidant status in senile diabetic and non-diabetic patients with myocardial infarction.
METHODS: The study included one hundred twenty six subjects. Out of them 31 were normal senile subjects, 33 were senile diabetic patients without myocardial infarction, 32 were senile diabetic patients with myocardial infarction and 30 were senile non-diabetic patients with myocardial infarction. The patients were selected on clinical grounds from National Institute of Cardiovascular Diseases, Karachi and Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
RESULTS: Serum fructose was significantly increased in senile diabetic patients with and without myocardial infarction and senile non-diabetic patients with myocardial infarction as compared with senile control subjects. Serum total antioxidant status was found to be significantly decreased in senile diabetic patients with and without myocardial infarction and senile non-diabetic patients with myocardial infarction as compared with senile control subjects. Fasting blood glucose, HbA (1C) and serum fructosamine were significantly increased in senile diabetic patients with or without myocardial infarction as compared with senile non-diabetic patients with myocardial infarction and senile control subjects. Negative significant correlation was observed between serum fructose and serum total antioxidant status in diabetic and non-diabetic patients with myocardial infarction. Positive significant correlation was observed between serum fructose and s-AGEs in diabetic and non-diabetic patients with myocardial infarction.
CONCLUSIONS: This study revealed that increased fructose concentration and decreased antioxidant status might have a role in the myocardial infarction. Copyright J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924606     DOI: 10.1055/s-0029-1202793

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

Review 1.  Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes.

Authors:  Michael A Via; Jeffrey I Mechanick
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

2.  Association of fructosamine to indices of dyslipidemia in older adults with type 2 diabetes.

Authors:  Kim E Innes; Terry Kit Selfe; Abhishek Vishnu
Journal:  Diabetes Metab Syndr       Date:  2010-12-30

3.  Lower Doses of Fructose Extend Lifespan in Caenorhabditis elegans.

Authors:  Jolene Zheng; Chenfei Gao; Mingming Wang; Phuongmai Tran; Nancy Mai; John W Finley; Steven B Heymsfield; Frank L Greenway; Zhaoping Li; David Heber; Jeffrey H Burton; William D Johnson; Roger A Laine
Journal:  J Diet Suppl       Date:  2016-09-28

4.  Glycemic Effects of Rebaudioside A and Erythritol in People with Glucose Intolerance.

Authors:  Dong Hee Shin; Ji Hye Lee; Myung Shin Kang; Tae Hoon Kim; Su Jin Jeong; Chong Hwa Kim; Sang Soo Kim; In Joo Kim
Journal:  Diabetes Metab J       Date:  2016-06-15       Impact factor: 5.376

Review 5.  Fructose Metabolism and Cardiac Metabolic Stress.

Authors:  M Annandale; L J Daniels; X Li; J P H Neale; A H L Chau; H A Ambalawanar; S L James; P Koutsifeli; L M D Delbridge; K M Mellor
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

6.  The relationships between serum fructosamine concentrations and lipid profiles in community-dwelling adults.

Authors:  You-Fan Peng; Ye-Sheng Wei
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.